Related Experiment Video

Updated: Aug 8, 2026

Measuring RAN Peptide Toxicity in C. elegans
10:49

Measuring RAN Peptide Toxicity in C. elegans

Published on: April 30, 2020

The rat N-ras gene; interference of pseudogenes with the detection of activating point mutations

H J van Kranen1, H van Steeg, L Schoren

  • 1Laboratory of Carcinogenesis and Mutagenesis, National Institute of Public Health and Environmental Protection, (RIVM), Bilthoven, The Netherlands.

Carcinogenesis
|February 1, 1994
PubMed

Insights

Detecting ras oncogene mutations using PCR is common, but rat N-ras pseudogenes interfere. This study shows pseudogenes cause sequence heterogeneity, complicating mutation screening and necessitating intron-specific amplification for accurate results.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Polymerase Chain Reaction (PCR) with oligonucleotide hybridization is standard for detecting activating point mutations in ras oncogenes.
  • Interference from non-target sequences can compromise the accuracy of mutation detection methods.

Purpose of the Study:

  • To investigate the interference of processed pseudogenes in the detection of activating point mutations in the rat N-ras gene using PCR.
  • To characterize the identified rat N-ras pseudogenes and their impact on mutation screening.

Main Methods:

  • PCR amplification of rat N-ras exon 1 using primers based on mouse sequences.
  • Sequence analysis of cloned PCR fragments to identify sequence heterogeneity.
  • Cloning and sequencing of wildtype N-ras, processed pseudogenes, and a portion of the unr gene.
  • Analysis of pseudogene effects on activating point mutation screening.

Main Results:

  • Sequence analysis revealed significant heterogeneity in PCR-amplified N-ras exon 1 fragments.
  • This heterogeneity was attributed to the presence of at least two distinct processed pseudogenes of the rat N-ras gene.
  • The genomic organization and nucleotide sequences of these pseudogenes were determined.
  • Confounding effects of pseudogenes on the screening for activating point mutations were demonstrated.

Conclusions:

  • Processed pseudogenes significantly interfere with the PCR-based detection of activating point mutations in the rat N-ras gene.
  • Accurate and unambiguous detection of N-ras activating point mutations requires intron-specific amplification strategies.
  • Understanding pseudogene interference is crucial for reliable genetic mutation analysis in oncogenes.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...